EUVIMEDEUVIMED entdecken
Crossref

Direct oral anticoagulant prescribing for atrial fibrillation: an Australian tertiary centre experience of ischaemic stroke complication

Vineel Lal iD, Cindy Yu, Krishnaa Sivapalan, Akashneel Lal, Ian Hughes, Christopher Morris

Internal Medicine Journal · 2026

DOI: 10.1111/imj.70325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2026. Verfasst von Vineel Lal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Anticoagulants, Factor Xa Inhibitors. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Direct oral anticoagulants (DOACs) have changed the paradigm of atrial fibrillation (AF) management in preventing ischaemic cerebrovascular accidents (CVAs). They are safe and effective in this aim. Their dosing is simpler than the vitamin K antagonist warfarin; however, there are certain nuances in dosing adjustments which clinicians must be aware of before initiating changes.

Aim

We sought to investigate the role of inappropriate DOAC underdosing in contributing to the development of ischaemic CVAs.

Methods

A retrospective cohort study was performed on all ischaemic CVA presentations to an Australian tertiary centre in the 12 months of 2023. We analysed all those already on DOAC therapy and the significance of inappropriate DOAC underdosing. This was compared to all DOAC prescriptions, without associated ischaemic CVA complication, within the centre during the same period and whether underdosing played a significant role.

Results

Seventy‐two patients presented to our centre with an ischaemic CVA, already prescribed and taking DOAC therapy. Underdosing of DOAC therapy, away from established guidelines, was the most common attributable factor found. Underdosing of DOACs had an overall odds ratio of 4.31, with a 95% confidence interval (95% CI) of 2.49–7.46, of suffering an ischaemic CVA. The periprocedural period was also found to be high risk for patients undergoing DOAC therapy.

Conclusions

Underdosing of DOAC therapy has a significant impact on whether individuals develop ischaemic CVAs. Clinicians must be stringent in applying dose reductions based on established guidelines and must be aware to review dosing for all their DOAC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationIschemic StrokeAnticoagulantsFactor Xa InhibitorsInappropriate PrescribingHumansRetrospective StudiesMaleFemaleAgedTertiary Care CentersAustraliaAdministration, OralAged, 80 and overMiddle Aged

Substanzen

AnticoagulantsFactor Xa Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Department of Medicine, Ipswich Hospital, Ipswich, Queensland, Australia.
  • Department of Medicine, Auckland City Hospital, Auckland, New Zealand.
  • Office for Research Governance and Development, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
  • Department of Clinical Pharmacology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

ORCID-Profile: Vineel Lal

Zitieren

APA

Lal, V., Yu, C., Sivapalan, K., Lal, A., Hughes, I., & Morris, C. (2026). Direct oral anticoagulant prescribing for atrial fibrillation: an Australian tertiary centre experience of ischaemic stroke complication. Internal Medicine Journal. https://doi.org/10.1111/imj.70325

Vancouver

Lal V, Yu C, Sivapalan K, Lal A, Hughes I, Morris C. Direct oral anticoagulant prescribing for atrial fibrillation: an Australian tertiary centre experience of ischaemic stroke complication. Internal Medicine Journal. 2026. doi:10.1111/imj.70325

BibTeX
@article{Lal2026,
  author = {Lal, Vineel and Yu, Cindy and Sivapalan, Krishnaa and Lal, Akashneel and Hughes, Ian and Morris, Christopher},
  title = {Direct oral anticoagulant prescribing for atrial fibrillation: an Australian tertiary centre experience of ischaemic stroke complication},
  journal = {Internal Medicine Journal},
  year = {2026},
  doi = {10.1111/imj.70325}
}
Kostenlos starten →